tiprankstipranks
Trending News
More News >
Solvay (SLVYY)
OTHER OTC:SLVYY
Advertisement

Solvay (SLVYY) AI Stock Analysis

Compare
53 Followers

Top Page

SLVYY

Solvay

(OTC:SLVYY)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
$3.50
▲(8.02% Upside)
Solvay's overall stock score reflects challenges in financial performance and technical analysis, partially offset by a favorable valuation and strategic initiatives highlighted in the earnings call. The company's ability to manage debt and improve cash flow will be crucial for future stability.
Positive Factors
Operational Excellence
The operational excellence initiative, focusing on digital transformation, is set to significantly reduce costs, enhancing long-term profitability.
Rare Earth Expansion
Expanding rare earth production positions Solvay to capitalize on growing demand for advanced materials, strengthening market position.
CO2 Emission Rights Optimization
Strategic optimization of CO2 rights provides a recurring revenue stream, enhancing cash flow and financial flexibility.
Negative Factors
Declining Revenue Growth
A decline in sales indicates challenges in maintaining market share and revenue growth, potentially impacting long-term financial health.
High Debt Levels
Increased leverage can strain financial resources, limiting the company's ability to invest in growth and manage economic downturns.
Challenges in Soda Ash Business
Persistent pricing pressure in soda ash could erode margins and profitability, affecting the company's competitive position in this segment.

Solvay (SLVYY) vs. SPDR S&P 500 ETF (SPY)

Solvay Business Overview & Revenue Model

Company DescriptionSolvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aircraft, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, specialty phenols, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the flavors and fragrances industries, as well as synthetic intermediates used in pharmaceuticals, agrochemicals, and electronics. This segment also provides friction reducers, gelling agents, emulsion breakers, surfactants, inhibitors, cementing additives, and biocides for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.
How the Company Makes MoneySolvay generates revenue through the sale of its advanced materials and specialty chemicals, which are utilized across various sectors. The company has key revenue streams from its Advanced Materials segment, which includes high-performance plastics and composites for the automotive and aerospace industries, and its Advanced Formulations segment, which provides specialty chemicals and formulations for industries such as consumer goods and pharmaceuticals. Additionally, Solvay benefits from long-term contracts with major clients, contributing to stable revenue streams. Strategic partnerships and collaborations with technology companies enhance its product offerings and create new market opportunities, further driving its earnings.

Solvay Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant achievements in operational excellence and strategic moves like CO2 emission rights optimization and rare earth expansion. However, these were counterbalanced by challenges in the soda ash and Coatis businesses, leading to an overall sales decline.
Q3-2025 Updates
Positive Updates
Operational Excellence and Digital Transformation
Solvay's operational excellence program is on track to generate EUR 350 million in cost savings by 2028. The company has already achieved EUR 110 million in 2024 and is on its way to exceed EUR 200 million by the end of 2025, primarily through digital transformation and condition-based monitoring.
CO2 Emission Rights Optimization
Solvay generated EUR 40 million EBITDA and EUR 50 million cash gain from selling part of their CO2 emission rights inventory in Q3. This strategic move is not a one-off and can be repeated depending on market conditions.
Rare Earth Expansion and Innovation
Solvay inaugurated a new production line for Nd-Pr oxide for permanent magnets at La Rochelle, France, and plans to expand capacity for other rare earth elements like samarium, dysprosium, and terbium by 2026.
Negative Updates
Challenging Market Conditions for Soda Ash
The soda ash business continues to face unsustainable pricing pressure due to overcapacity in China, leading to reduced production in European export plants.
Decline in Coatis Business
The Coatis business experienced a 26% decline in sales due to strong competition from Asian players and high tariffs on Brazilian imports to the U.S.
Overall Sales Decline
Underlying net sales in Q3 2025 reached EUR 1.040 billion, down 7% compared to Q3 2024, with volumes down 4% year-on-year.
Company Guidance
During Solvay's Third Quarter and First 9 Months of 2025 earnings call, the company provided guidance amidst a challenging macroeconomic environment. They reported a 7% year-on-year decline in Q3 net sales to EUR 1.040 billion and a similar decrease in underlying EBITDA to EUR 232 million, maintaining a solid EBITDA margin of 22%. Despite pressures, particularly in the Coatis and soda ash businesses due to geopolitical and market challenges, Solvay generated EUR 117 million in free cash flow in Q3, totaling EUR 214 million for the first nine months. They benefited from a strategic EUR 40 million EBITDA gain from selling part of their CO2 emission rights inventory, resulting in a EUR 50 million cash gain. Solvay expects full-year 2025 EBITDA between EUR 880 million and EUR 930 million and aims for free cash flow from continuing operations of around EUR 300 million with CapEx capped at EUR 300 million, ensuring dividend coverage.

Solvay Financial Statement Overview

Summary
Solvay's financial performance is challenged by declining revenue growth and profitability, with increased leverage and declining cash flow metrics. Operational efficiency remains a strength, but strategic initiatives are needed to boost revenue and improve cash flow conversion.
Income Statement
65
Positive
Solvay's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth rate and margins compared to previous years. The gross profit margin and net profit margin have decreased, reflecting challenges in maintaining profitability. However, the company has managed to maintain a positive EBIT and EBITDA margin, indicating operational efficiency. The revenue growth rate has been negative, suggesting a need for strategic adjustments to drive growth.
Balance Sheet
70
Positive
The balance sheet reveals a high debt-to-equity ratio, which has increased in the TTM period, indicating higher financial leverage and potential risk. However, the return on equity remains positive, albeit lower than previous years, suggesting that the company is still generating returns for shareholders. The equity ratio indicates a stable capital structure, but the rising debt levels could pose a risk if not managed effectively.
Cash Flow
60
Neutral
Cash flow analysis shows a decline in free cash flow growth, with negative growth in the TTM period. The operating cash flow to net income ratio remains positive, indicating that the company is generating cash from its operations. However, the free cash flow to net income ratio has decreased, reflecting challenges in converting earnings into free cash flow. This could impact the company's ability to invest in growth opportunities or reduce debt.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.95B5.13B6.02B16.07B11.44B9.71B
Gross Profit1.05B1.15B1.38B4.03B2.93B2.51B
EBITDA660.00M805.00M1.31B1.36B1.95B1.75B
Net Income139.00M223.00M2.09B1.91B948.00M-1.09B
Balance Sheet
Total Assets6.30B6.69B7.02B20.66B20.05B16.79B
Cash, Cash Equivalents and Short-Term Investments345.00M555.00M711.00M1.69B2.27B1.22B
Total Debt2.23B2.14B2.19B2.96B3.35B3.51B
Total Liabilities5.09B5.29B5.72B10.00B11.20B9.49B
Stockholders Equity1.14B1.34B1.26B10.60B8.74B7.20B
Cash Flow
Free Cash Flow243.00M330.00M847.00M1.10B863.00M707.00M
Operating Cash Flow548.00M615.00M1.91B2.01B1.50B1.24B
Investing Cash Flow-284.00M-281.00M-1.79B-831.00M-470.00M711.00M
Financing Cash Flow-397.00M-364.00M-455.00M-1.19B-1.10B-1.69B

Solvay Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.24
Price Trends
50DMA
3.17
Positive
100DMA
3.22
Positive
200DMA
3.33
Negative
Market Momentum
MACD
0.03
Negative
RSI
57.52
Neutral
STOCH
71.77
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SLVYY, the sentiment is Positive. The current price of 3.24 is above the 20-day moving average (MA) of 3.17, above the 50-day MA of 3.17, and below the 200-day MA of 3.33, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 57.52 is Neutral, neither overbought nor oversold. The STOCH value of 71.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SLVYY.

Solvay Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$3.12B20.9110.62%9.17%-4.18%-90.40%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
$1.80B-10.65%13.48%-3.46%-191.77%
53
Neutral
$4.55B-54.74%0.29%-7.34%-382.79%
49
Neutral
$16.96B-6.39%8.84%-5.25%-208.14%
47
Neutral
$1.14B-10.68%36.31%
46
Neutral
$610.43M-18.65%8.88%-7.81%-334.15%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SLVYY
Solvay
3.27
0.08
2.51%
CE
Celanese
41.84
-28.88
-40.84%
BAK
Braskem SA
3.07
-2.04
-39.92%
HUN
Huntsman
10.61
-8.22
-43.65%
TROX
TRONOX
3.94
-7.21
-64.66%
DOW
Dow Inc
23.76
-16.11
-40.41%

Solvay Corporate Events

Solvay SA ADR Reports Challenging Q3 2025 Performance
Nov 7, 2025

Solvay SA ADR is a global chemical company operating in the specialty chemicals and advanced materials sectors, known for its focus on sustainable solutions and energy transition projects. In its latest earnings report for the first nine months of 2025, Solvay highlighted a challenging market environment, particularly in the Southeast Asian soda ash market, leading to a decline in net sales and EBITDA compared to the previous year. Despite these challenges, the company achieved significant cost savings and optimized its portfolio of CO2 emissions rights, contributing positively to its EBITDA and free cash flow. Key financial metrics showed a decrease in net sales by 9.7% year-over-year for Q3 2025, with an EBITDA margin of 22.2%. The company also reported a free cash flow of €117 million for the quarter, supported by strategic asset optimization. Looking ahead, Solvay remains confident in meeting its 2025 objectives, with expectations of an underlying EBITDA between €880 million and €930 million and a free cash flow of around €300 million, as it continues to focus on disciplined investments and structural cost savings.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 10, 2025